remember corecpt therapeutics testing mifepristone aka ru corlux psychotic depression well things go exactly planned indicated earlier found medication efficacious placebo depression one trial result replicated second failed trial one admire ability make excuses press release states case study prior failed trial unusually high placebo response rate study else fails blame placebo two failed trials corcept marches enrolling patients third trial plan announce results early cpp blog i watching anxiously get one three fda give stamp approval course one guess dr charles nemeroff felt latest turn events scientific advisory board corcept stock really took beating one day upon release second negative trial may remember chuck researcher published positive comments review article regarding mifepristone based study containing whopping sample five patients article contained disclosure conflicts interests fact advisory board company whose drug pimping based skimpy data refresh memory story let hope sake able move shares latest press release issued